Jaguar Health Inc (JAGX)
0.292
-0.02
(-5.65%)
USD |
NASDAQ |
May 10, 16:00
0.2969
0.00 (0.00%)
After-Hours: 18:08
Jaguar Health Shareholders Equity (Quarterly): 4.961M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.961M |
| September 30, 2023 | 1.36M |
| June 30, 2023 | 5.637M |
| March 31, 2023 | 7.35M |
| December 31, 2022 | -0.657M |
| September 30, 2022 | 3.647M |
| June 30, 2022 | 2.716M |
| March 31, 2022 | 8.045M |
| December 31, 2021 | 11.61M |
| September 30, 2021 | 21.55M |
| June 30, 2021 | 31.78M |
| March 31, 2021 | 31.89M |
| December 31, 2020 | 17.20M |
| September 30, 2020 | 7.806M |
| June 30, 2020 | 1.544M |
| March 31, 2020 | 6.233M |
| December 31, 2019 | 10.67M |
| September 30, 2019 | 20.38M |
| June 30, 2019 | 7.356M |
| Date | Value |
|---|---|
| March 31, 2019 | 6.796M |
| December 31, 2018 | 5.383M |
| September 30, 2018 | 10.32M |
| June 30, 2018 | 14.02M |
| March 31, 2018 | 21.01M |
| December 31, 2017 | 17.26M |
| September 30, 2017 | 31.81M |
| June 30, 2017 | -6.267M |
| March 31, 2017 | -6.191M |
| December 31, 2016 | -2.454M |
| September 30, 2016 | -0.273M |
| June 30, 2016 | 1.565M |
| March 31, 2016 | 4.648M |
| December 31, 2015 | 4.399M |
| September 30, 2015 | 8.366M |
| June 30, 2015 | 11.11M |
| March 31, 2015 | -11.85M |
| December 31, 2014 | -0.9303M |
| June 30, 2014 | -3.901M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.657M
Minimum
Dec 2022
31.89M
Maximum
Mar 2021
10.58M
Average
7.356M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| BioSig Technologies Inc | -2.913M |
| BioVie Inc | 7.491M |
| First Wave BioPharma Inc | 3.603M |
| Genprex Inc | 7.416M |
| Adial Pharmaceuticals Inc | 4.084M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.76M |
| Total Liabilities (Quarterly) | 45.87M |
| Debt to Equity Ratio | 7.228 |
| Current Ratio | 1.999 |
| Net Debt Paydown Yield | -7.41% |